SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (18968)2/21/1999 12:32:00 PM
From: BigKNY3  Read Replies (12) of 23519
 
Vlad: <<This coming week should be revealing:1)February 24--short interest numbers published 2)February 24--exactly 3 months since the last Viagra body count released by the FDA. New tally due. Now we include a lot of new patients as new international markets have opened. >>

V-man: Two questions for you to ponder:

Can you document that any negative Viagra news has ever had more than a one day effect on the price of VVUS?

Assume that there was never any negative Viagra reports published in the news, do you think the price of VVUS would be lower than it is today?

Bottom-line: As first posted on March 15, 1998 (pre-Viagra approval), I believe the price of VVUS is still primarily related to the level of US MUSE Rx specification and investor perception of its future direction.

Message 3715970

BigKNY3
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext